Precision Medicine Advances Will Transform Global Healthcare Analytics

Published
02 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
US$7.00
50.4% undervalued intrinsic discount
15 Aug
US$3.47
Loading
1Y
6.4%
7D
9.1%

Author's Valuation

US$7.0

50.4% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on06 Aug 25
Fair value Decreased 3.45%

SOPHiA GENETICS' consensus price target has been reduced to $6.75, primarily reflecting lowered revenue growth expectations despite a modest improvement in net profit margin. What's in the News SOPHiA GENETICS reiterated its full-year 2025 revenue guidance of $72 million to $76 million.

Shared on01 May 25

Shared on24 Apr 25
Fair value Increased 7.73%

Shared on17 Apr 25
Fair value Decreased 3.44%

AnalystConsensusTarget has increased revenue growth from 20.3% to 22.7% and decreased shares outstanding growth rate from 0.0% to 0.0%.

Shared on09 Apr 25
Fair value Increased 3.11%

AnalystConsensusTarget has increased profit margin from 12.2% to 14.7% and decreased future PE multiple from 41.8x to 36.3x.